Citation Impact

Citing Papers

Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Origin of myofibroblasts in the fibrotic liver in mice
2014
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Copper-free click chemistry in living animals
2010 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice
2016
Bile acid transporters
2009
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
2012
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
2012
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Scraping fibrosis: Expressway to the core of fibrosis
2011
Molecular diagnosis and treatment of drug-resistant hepatitis B virus
2014
Acute kidney injury
2012 Standout
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
2012
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
2013
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
2011
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #
2009
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes
2011
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice
2011
Mechanisms of hepatic stellate cell activation
2017 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Hepatic Stellate Cells and Liver Fibrosis
2013
Long-term culture and expansion of primary human hepatocytes
2015
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
2014
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
2012
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Function, structure and therapeutic potential of complement C5a receptors
2007
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
CX3CL1-CX3CR1 Interaction Prevents Carbon Tetrachloride-Induced Liver Inflammation and Fibrosis in Mice
2010
Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells
2013
Intensive Care Unit Management of Patients with Liver Failure
2014
Liver: An organ with predominant innate immunity
2007
The biology and function of fibroblasts in cancer
2016 Standout
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis
2015
Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list
2013
Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus
2008
Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4
2015
Hepatocellular carcinoma
2021 Standout
Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis
2012
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
2014
Chemokines in the immunopathogenesis of hepatitis C infection #
2008
Complement: a key system for immune surveillance and homeostasis
2010 Standout
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
2014
Pathological bacterial translocation in liver cirrhosis
2013
Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine
2007
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Fibroblast-mediated drug resistance in cancer
2013
Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis
2010
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Metazoan MicroRNAs
2018 Standout
Acute kidney injury
2019 Standout
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination
2015
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
2016
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
2013
Evolving challenges in hepatic fibrosis
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
The Stages of Type 1A Diabetes
2005
Type 1 diabetes
2013 Standout
Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis
2015
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
EMT: 2016
2016 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis
2011
REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION
2007
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
2016
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Management of Sepsis During MARS Treatment in Acute on Chronic Liver Failure
2011
Acute-on-chronic Liver Failure
2016
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis
2010
Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis
2013
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
2012
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
2016
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome
2014
Tenofovir Improves the Outcome in Patients with Spontaneous Reactivation of Hepatitis B Presenting as Acute-On-Chronic Liver Failure §Δ
2010
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
2001
The mouse as a model for human biology: a resource guide for complex trait analysis
2006
CXCR3 ligands in disease and therapy
2014
CCR1 and CCR5 promote hepatic fibrosis in mice
2009
Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis†
2009
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular carcinoma
2022 Standout
Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
2021
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Novel functions of platelets in the liver
2015
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
2014
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
2012
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Nanoparticles in Photodynamic Therapy
2015 Standout
Synthesis of Sulfotyrosine‐Containing Peptides by Incorporating Fluorosulfated Tyrosine Using an Fmoc‐Based Solid‐Phase Strategy
2015 StandoutNobel
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Role of platelets in chronic liver disease and acute liver injury
2013
The carbon tetrachloride model in mice
2015
Dexamethasone in outcome of patients with hepatitis B virus‐related acute‐on‐chronic liver failure
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
2017
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
2014
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
2013
Altered immune function of monocytes in different stages of patients with acute on chronic liver failure
2006
Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
2012
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
2012

Works of Hermann E. Wasmuth being referenced

Functional role of chemokines in liver disease models
2010
The Chemokine CCL3 Promotes Experimental Liver Fibrosis in Mice
2013
Cow’s milk and immune-mediated diabetes
2000
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
2010
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
2005
Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver
2005
Chemokines in Liver Inflammation and Fibrosis
2010
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
2012
Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases
2011
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
2012
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection
2007
CC chemokine receptor 5 ?32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia
2004
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
2009
CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis†
2009
Chemokine-directed immune cell infiltration in acute and chronic liver disease
2008
Strong activation of bile acid-sensitive ion channel (BASIC) by ursodeoxycholic acid
2012
Proapoptotic Effects of the Chemokine, CXCL 10 Are Mediated by the Noncognate Receptor TLR4 in Hepatocytes
2012
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
2010
The Marburg I variant (G534E) of the factor VII–activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet‐derived growth factor BB†
2008
Overexpression of Endoglin Modulates TGF-β1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line
2013
Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells
2012
Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration
2008
Chemokines in tissue fibrosis
2012
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
2009
Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
2004
Longitudinal monocyte Human leukocyte antigen‐DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis
2009
Non-specific viral infections as possible synchronising events of the manifestation of Type 1 diabetes
2000
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection
2009
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74
2011
Rankless by CCL
2026